FEB 26 (TUE) - MNKD 2018 4Q + Full Year Financial Results

[kite]

www.globenewswire.com/news-release/2019/02/19/1737956/0/en/MannKind-Corporation-to-Hold-2018-Fourth-Quarter-and-Full-Year-Financial-Results-Conference-Call-on-February-26-2019.html


WESTLAKE VILLAGE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2018 fourth quarter and full year financial results on Tuesday, February 26, 2019 and its management will host a conference call to discuss the financial results and other Company developments at 9:00 AM (Eastern Time) on February 26, 2019.

Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder.

To participate in the live call by telephone, please dial [phone] or [phone] and use the participant passcode: 7809405. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at www.mannkindcorp.com under News & Events.

A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing [phone] or [phone] and use the participant passcode: 7809405#. A replay will also be available on MannKind's website for 14 days.

About MannKind Corporation
MannKind Corporation (NASDAQ: MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, the Company’s first FDA-approved product and the only inhaled rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com.

Company Contact:
Rose Alinaya
SVP, Investor Relations
818-661-5000
[e-mail]

[centralcoastinvestor]

The report date is sooner than what I was expecting.  Does anyone know the latest date that they could have reported? And how close is this to the UTHR reporting date?

[peppy]

Feb 19, 2019 17:09:40 GMT -5 centralcoastinvestor said:

The report date is sooner than what I was expecting.  Does anyone know the latest date that they could have reported? And how close is this to the UTHR reporting date?

UTHR reported last, October 31, 2018
no reporting date released as of yet.
ir.unither.com/press-releases

[mcloven]

Not sure but they reported on 2/28 last year.

[awesomo]

UTHR reported on 2/22/18 last year.
MNKD reported on 2/27/18 last year before market open.

So nothing really out of the ordinary, and I expect the call to be the same.

[bigchungus91354]

Maybe they will update their pipeline page after the ER call.

[liane]

What's with the AM cc? Some of us are working at that hour.

[sla55]

Last year, Chief Commercial Officer, Pat McCauley and Chief Medical Officer, David Kendall were also presenting from the Company. 

[traderdennis]

Feb 19, 2019 17:09:40 GMT -5 centralcoastinvestor said:

The report date is sooner than what I was expecting.  Does anyone know the latest date that they could have reported? And how close is this to the UTHR reporting date?

IIRC matt explained that q4 reporting dates are based on when the company can have their audit finished versus when they want to report.  Smaller companies like MNKD have to wait until the big audit firms are finished with their higher paying clients.

[mytakeonit]

Feb 19, 2019 18:02:54 GMT -5 liane said:

What's with the AM cc? Some of us are working at that hour.

What's with the AM cc?  Some of us are sleeping at that hour.

... (snicker snicker)

[buyitonsale]

Yeah, nothing special to be expected, just a profitable 4th quarter, probably around 25 to 30M in the black 😊

[Clement]

Feb 19, 2019 17:09:40 GMT -5 centralcoastinvestor said:

The report date is sooner than what I was expecting.  Does anyone know the latest date that they could have reported? And how close is this to the UTHR reporting date?

United Therapeutics Corporation To Report Fourth Quarter And Annual 2018 Financial Results Before The Market Opens On Wednesday, February 27, 2019

9:00 am eastern

ir.unither.com/

[Clement]

What a coincidence!   --- re: dry powder inhaled treprostinil

On Feb 13, Liquidia announced their EC will be on Feb 26 at 8:00 am.

On Feb 19, Mannkind announced their EC will be on Feb 26 at 9:00 am.

[matt]

Feb 19, 2019 17:09:40 GMT -5 centralcoastinvestor said:

The report date is sooner than what I was expecting.  Does anyone know the latest date that they could have reported? And how close is this to the UTHR reporting date?

The SEC required reporting date is based on the company size.  Most companies are "accelerated filers" and must report 75 days after year end (i.e. on or before March 18).  United Therapeutics is a "large accelerated filer" and must report 60 days after year end (i.e. on or before March 1).  March 18 is more than 75 days, but the actual due date is on a weekend so the date slides forward to Monday, and the company can apply for a slightly extended filing date.

As somebody noted above, what really matters is when the audit is sufficiently complete that the accountants have signed off.  If the auditors have signed off by February 1, a company can report on February 2.  You can find a few large companies with very stable businesses that report as early as mid-January because their sales are sufficiently predictable that the auditors let them do a hard cut-off in mid-December and they simply estimate the last few weeks of the year.  Auditors tend to focus on their largest clients due to the earlier reporting date, and a company the size of MNKD is doing well to report by the end of February.

[bigchungus91354]

Does anyone know the estimated EPS for the Q?